Deliver Your News to the World

Products Cleared by FDA, now 510K approved


WEBWIRE

ANIARA CORPORATION GROWTH DRIVEN BY GLOBAL PRESENCE AND EXTENSIVE PRODUCT OFFERING FOR MEDICAL EXPLORATION AND DISCOVERY

Mason, OH – Aniara Corporation, a multi-national distributor of diagnostic and research agents, as well as screening tools, has strengthened its commitment to meeting today’s highest standards for product quality and cost-efficient delivery.

Hyphen BioMed products now cleared by FDA (510K) and is now available for in vitro use exclusively from Aniara Corporation.

BioPhen Antithrombin 2.5 (Chromogenic)

BioPhen Antithrombin 5.0 (Chromogenic)

BioPhen Protein C 2.5 (Chromogenic)

BioPhen Protein C 5.0 (Chromogenic)

BioPhen Plasma Calibrator

BioPhen Plasma Control Normal

BioPhen Plasma Control Abnormal

BioPhen Heparin Calibrator

BioPhen UHF Calibrator

BioPhen LMWH Control Plasma

BioPhen LMWH Control Plasma Low

BioPhen UHF Control Plasma


Aniara introduces two new products to the market:

Chromogenic BioPhen Prothrombin assay

Chromogenic BioPhen Factor X assay


Aniara Corporation provides complete line of diagnostic and research reagents for thrombosis, hemostasis, and autoimmunity from Hyphen BioMed, that many are CE and 510K cleared. Kits are configured and/or customized to meet specific needs, while minimizing waste and prolonging shelf life. These products can be purchased at a significant discount through Aniara’s Research Value Program. Aniara offers bulk discount and custom made products.

Within that same product realm, Aniara Corporation sponsors an annual Coagulation Research Grant – $5,000.00 awarded to “established” investigators or “students/trainees” for a specialized project within the coagulation/hematology scientific field. Additionally, the Aniara CHTAE Committee selects a North American recipient, each year, to honor with the Coagulation/Hemostasis Technologist Award for Excellence. The honoree also receives a $1,000.00 check at the annual ASH meeting.

www.aniara.com



WebWireID9202





This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.